Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-22-001756
Filing Date
2022-10-28
Accepted
2022-10-28 11:07:28
Documents
3
Period of Report
2022-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K sndl6k.htm 6-K 13834
2 NEWS RELEASE DATED OCTOBER 28, 2022 ex991.htm EX-99.1 4447
3 GRAPHIC logo.jpg GRAPHIC 4781
  Complete submission text file 0001279569-22-001756.txt   26102
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 221339741
SIC: 2833 Medicinal Chemicals & Botanical Products